Head, Translational Research Unit
Dynamics and Replication Program
Center for Cancer Research
National Cancer Institute
P.O. Box B,
Frederick, MD 21702-1201
Dr. Mary Kearney received her Ph.D. in Biology at Catholic University in 2007 under the direction of Drs. John Coffin, Sarah Palmer, and Venigalla Rao. In 2001 she joined the HIV Drug Resistance Program (renamed as the HIV Dynamics and Replication Program in 2015) as a Biologist in the Virology Core and in 2008 she was promoted to Manager of the Virology Core, now called the Translational Research Unit (TRU). In her current position as Head of the TRU, Dr. Kearney oversees a team that investigates HIV genetics and expression in vivo, the sources of persistent viremia during antiretroviral therapy (ART), the sources of rebound viremia after stopping ART, the mechanisms for maintaining the HIV reservoir, and the mechanisms for the emergence of HIV drug resistance mutations. Dr. Kearney was awarded the NIH Director’s Award in 2012 and the NCI Director's Award in 2015, was the keynote speaker for the launch of the Bioinformatics Program at Hood College in 2015, and is a consultant for the World Health Organization and advisor and adjunct professor in the biology department at Hood College.
modified: 21 October 2015